SpyGlass Pharma, Inc.
SGPNasdaq
$19.77
↓ -4.8%Jul 17 close · end-of-day
Price
1Y↓ -25.1%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$43.8M
Enterprise Value
-$195.1M
P/E
—
P/S
—
P/B
0.2
EV/EBITDA
—
PEG
—
FCF Yield
-76.4%
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$39.9M
Free Cash Flow (TTM)
-$33.5M
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-15.9%
ROIC
-292.1%
Debt / Equity
—
Net Cash
$238.9M
Return 1Y
—
Company profile
We are a late-stage biopharmaceutical company dedicated to transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. Our principal executive offices are located in Aliso Viejo, California.
- CEO
- Patrick Mooney
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 65
- Headquarters
- California
- Website
- www.spyglasspharma.com
Earnings
SGP Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue——
Diluted EPS-$0.69↓ -82.6%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2024 | FY2025 |
|---|---|---|
| Revenue | — | — |
| Gross profit | — | — |
| Operating income | -$27.1M | -$41.4M |
| Net income | -$29.2M | -$39.9M |
| Diluted EPS | -$16.31 | -$17.98 |
| Operating cash flow | -$22.0M | -$32.7M |
| Free cash flow | -$24.0M | -$33.5M |
| Gross margin | — | — |
| Operating margin | — | — |
| Net margin | — | — |
| Line item | Q1 '25 | Q1 '26 |
|---|---|---|
| Revenue | — | — |
| Gross profit | — | — |
| Operating income | -$7.4M | -$15.4M |
| Net income | -$8.8M | -$13.8M |
| Diluted EPS | -$3.96 | -$0.69 |
| Operating cash flow | -$8.2M | -$13.5M |
| Free cash flow | -$8.4M | -$14.2M |
| Gross margin | — | — |
| Operating margin | — | — |
| Net margin | — | — |
Company news
Jun 2, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-02-09 | RA CAPITAL MANAGEMENT, LLC | Buy | 3,441,966 | $16.00 | $55.1M | filing |
| 2026-02-09 | Behbahani Ali | Buy | 937,500 | $16.00 | $15.0M | filing |
| 2026-02-09 | SANDELL SCOTT D | Buy | 937,500 | $16.00 | $15.0M | filing |
| 2026-02-09 | Walker Paul Edward | Buy | 937,500 | $16.00 | $15.0M | filing |
| 2026-02-09 | New Enterprise Associates 17, L.P. | Buy | 937,500 | $16.00 | $15.0M | filing |
| 2026-02-09 | Yang Rick | Buy | 937,500 | $16.00 | $15.0M | filing |
| 2026-02-09 | Florence Anthony A. Jr. | Buy | 937,500 | $16.00 | $15.0M | filing |
| 2026-02-09 | Makhzoumi Mohamad | Buy | 937,500 | $16.00 | $15.0M | filing |
| 2026-02-09 | Chang Carmen | Buy | 937,500 | $16.00 | $15.0M | filing |
| 2026-02-09 | BASKETT FOREST | Buy | 937,500 | $16.00 | $15.0M | filing |
| 2026-02-09 | Mathers Edward T | Buy | 937,500 | $16.00 | $15.0M | filing |
| 2026-02-09 | Pardo Geoffrey B | Buy | 312,500 | $16.00 | $5.0M | filing |
| 2026-02-09 | RA CAPITAL MANAGEMENT, LLC | Buy | 248,034 | $16.00 | $4.0M | filing |
| 2026-02-09 | Vensana Capital I GP, LLC | Buy | 165,000 | $16.00 | $2.6M | filing |
| 2026-02-09 | Nielsen Kirk G. | Buy | 165,000 | $16.00 | $2.6M | filing |
| 2026-02-09 | Khan Bilal Arshad | Buy | 115,000 | $16.00 | $1.8M | filing |
| 2026-02-09 | Khan Bilal Arshad | Buy | 20,000 | $16.00 | $320,000.00 | filing |
| 2026-02-09 | Pardo Geoffrey B | C | 1,875,013 | $0.00 | $0.00 | filing |
| 2026-02-09 | BASKETT FOREST | C | 737,962 | — | — | filing |
| 2026-02-09 | Behbahani Ali | C | 402,273 | — | — | filing |
| 2026-02-09 | BASKETT FOREST | C | 1,370,168 | — | — | filing |
| 2026-02-09 | BASKETT FOREST | C | 1,370,168 | — | — | filing |
| 2026-02-09 | Behbahani Ali | C | 954,990 | — | — | filing |
| 2026-02-09 | BASKETT FOREST | C | 402,273 | — | — | filing |
| 2026-02-09 | New Enterprise Associates 17, L.P. | C | 1,619,240 | — | — | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.